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1. Introduction 
Nutritional science has become more and more focused on foods and food components that 
have the potential to optimize the physical and mental state of the consumer, as well as to 
reduce the risk of disease. In our laboratory, we aim to design food products for a healthy 
diet and to decrease the risk of suffering from chronic diseases, especially those that become 
more prevalent with advancing age.  
Our emphasis is on food or food additives and feed with added coenzyme Q10 (CoQ10), or 
ubiquinone. CoQ10 is a key component in the inner mitochondrial membrane, where it plays 
important role in oxidative phosphorylation (Lenaz et al., 2007). It is also present in other 
subcellular fractions and in plasma lipoproteins, where it acts as an important antioxidant 
(Bentinger et al., 2007). CoQ10 has also been shown to have an effect on gene expression 
(Littarru & Tiano, 2007). These three functions are important for its use in clinical practice 
and in food supplementation.  
CoQ10 can be found in various foods in different concentrations. The richest nutritional 
sources of CoQ10 are meat, fish, nuts, and some oils. CoQ10 can also be found in vegetables, 
fruits, cereals, and dairy products but at much lower levels (Mattila & Kumpulainen, 2001). 
The average contribution from food sources is 3-5 mg of CoQ10 a day for a healthy 
individual according to Weber et al. (1997). This amount can be easily consumed with 
normal food. In cases of deficiency, the contribution from food intake would have to be 
higher than 100 mg per day. This amount cannot be obtained only through food and 
therefore supplemental doses of CoQ10 must be given to the patient. It is known that the 
absorption of exogenously administering CoQ10 is slow and limited due to its lipophilic 
nature and relatively high molecular weight (Mr = 863), which is consequently reflected in 
its relatively poor bioavailability. However, increasing its solubility in aqueous medium 
should, in most cases, increase its bioavailability, which is why, we developed a soluble 
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form of CoQ10 that was later patented in the form of complex with ǃ-cyclodextrin (ǃ-CD) 
(Prošek et al., 2005). This new form of CoQ10 exhibits increased water solubility and, 
consequently, better bioavailability in comparison to powder and oil-based CoQ10 
preparations (Prošek et al., 2008; Žmitek et al., 2008). This new form of CoQ10 has already 
been commercialized as a functional food additive for human nutrition. 
Our first selection for the practical use of this product was a group of dairy products 
(Stražišar et al., 2005). Their blend of fat and water was the ideal base for application of a 
functional food additive with an increased amount of CoQ10. Later, we found different 
meats (fish, poultry, beef and pork) and different kinds of pates suitable for fortification 
with water soluble CoQ10. 
Our first attempt to evaluate the effect of CoQ10 on living organisms was on free living non-
laboratory broiler chickens. That study covered the accumulation of the CoQ10 in different 
parts of the chicken's body (blood, heart, liver, and different muscle tissue) after different 
periods of administration (up to 40 days). For this purpose, 200 chickens, provenance ROSS 
308, were used. Tests were carried out under optimal breeding and health conditions. Two 
different types of fodders (BRO-G and BRO-F2) were prepared in order to cover the needs of 
40-day period. An adequate amount of water-soluble substance in the form of a paste with 
7.5 % CoQ10 was weighed and mixed in consecutive steps until a final concentration was 
obtained. The daily dose was set at 5 mg CoQ10 per animal per day. For a better 
understanding of CoQ10 accumulation, its distribution on the cellular level was studies by 
analyzing several subcellular fractions of breast muscle tissue (Jazbec et al., 2009). 
We also tested the performance of poultry meat in industrial production with an increased 
quantity of CoQ10 in an industrial scale experiment, where 37000 chickens were fed fodder 
enriched with CoQ10 for the last 20 days before slaughtering. Fortified fodder was prepared 
as shown later in the text. In such a manner, we prepared natural functional meat products, 
which are more resistant to the potentially harmful effects of free radicals.  
2. Ubiquinone 
2.1 Properties of ubiquinone  
Coenzyme Q10 (CoQ10) is a lipid soluble molecule composed of a quinoid head and a 
hydrophobic tail, which contains 10 isoprenoid units (Fig. 1). It is an essential player in 
oxidative phosphorylation in the mitochondria and has an important role in the formation 
of ATP (Ernster & Dallner, 1995). It also maintains the fluidity of cellular and mitochondrial 
membranes and acts as an important antioxidant, which efficiently protects phospholipids, 
mitochondrial DNA, and membrane proteins from free radicals (Ernster & Dallner, 1995; 
Littarru, 1994; Crane, 2001; Bentinger et al., 2007) 
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Fig. 1. Structure of CoQ10 (in the form of ubiquinol) 
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2.2 Biosynthesis of ubiquinone 
CoQ10 is endogenously synthesized in all human and animal cells (Olson & Rudney, 1983; 
Elmberger et al., 1987). It can also be administered via dietary uptake through food and 
dietary supplements. The biosynthesis of CoQ10 includes two pathways. The biosynthesis of 
the polyprenyl side chain runs through the mevalonate pathway. The reaction starts from 
acetyl-coenzyme A and ends up with farnesyl pyrophosphate (FPP). FPP is also the 
substrate for the biosynthesis of isoprenylated proteins, dolichol and cholesterol. The 
quinone head is synthesized from tyrosine and in some cases from phenylalanine (Turunen 
et al., 2004). 
2.3 Intake of CoQ10 with food and their absorption 
CoQ10 can be administered with plant and animal food. The richest sources of dietary CoQ10 
are meat and fishes, due to their relatively high levels of mitochondria. Dairy products and 
vegetables are much poorer in CoQ10, when compared to animal tissues. The average daily 
intake of CoQ10 is estimated to be under 10 mg (Weber et al., 1997; Mattila & Kumpulainen, 
2001). 
Due to the lipophilic nature of CoQ10 its absorption follows the same process as that of fat-
soluble nutrients in the gastrointestinal tract (Bhagavan & Chopra, 2006). Following 
absorption, CoQ10 is first incorporated into chylomicrons and is taken up rapidly by the 
liver where CoQ10 is repackaged into very low density protein/low density protein particles 
(VLDL/LDL) and released into circulation (Kaikkonen et al., 2002).  
3. Complex of CoQ10 with β-cyclodextrine 
CoQ10 is classified as a lipophilic compound and is practically insoluble in aqueous 
solutions. Due to its high molecular weight and poor water solubility, it is absorbed from 
the gastrointestinal tract poorly and slowly. Mainly soft and hard gel capsules filled with 
powder or CoQ10 dispersed in sesame or soybean oil are available as a nutritional 
supplements on the market. Therefore, it has been a challenge to develop a CoQ10 
formulation for oral administration with better water-solubility and therefore better 
bioavailability.  
Different methods have been used to improve the solubility of CoQ10. Some approaches 
have included the preparation of nanoparticles incorporating CoQ10 (Hsu et al., 2003; 
Ankola et al., 2007), solubilization in a blend of sorbitan monooleate, polysorbate 80, 
medium chain triglycerides, propylene glycol, ǂ-tocopherol and poly vinyl pyrrolidone 
(Chopra et al., 1998), preparation of redispersible dry emulsion (Takeuchi et al., 1992), solid 
dispersion of CoQ10 with Eudragit® (Nazzal et al., 2002), and fine oil-in-water emulsion via 
the development of a self-emulsifying drug delivery system (Kommuru et al., 2001). The 
most recent preparation of CoQ10 is All-Q® 10% CWS/S, which is based on food grade 
starch (Ullmann et al., 2005). Some of the most useful enzyme-modified starch derivatives 
are cyclodextrins, which are well known as inclusion-complexing agents for small and large 
molecules (Szejtli, 1998).  
The most common cyclodextrin (CD) is ǃ-CD, a ring molecule consisting of seven 
glucopyranose units. Having a hydrophilic outer surface and a hydrophobic inner cavity 
www.intechopen.com
 
Trends in Vital Food and Control Engineering 168 
gives it a unique ability to form inclusion complexes with lipophilic compounds and 
increase their water-solubility, stability and/or bioavailability (Doorne, 1993). Lutka and 
Pawlaczyk (1995) tried to synthesize inclusion complexes of CoQ10 with various CDs. They 
prepared inclusion complexes of CoQ10 with Ǆ-cyclodextrin (Ǆ-CD) and substituted Ǆ-CDs 
using “kneading” and “heating” methods, but they could not confirm a complex with either 
non-substituted ǃ-CD or with ǃ-CD. 
In the Laboratory for Food Chemistry at the National Institute of Chemistry Slovenia, we 
participated in the development of a water-soluble form of CoQ10, which could be used in 
the preparation of functional foods. For this purpose, we prepared complexes of CoQ10 with 
-CD by a co-precipitation method in aqueous solution (Fig. 2). The complex of CoQ10 with 
ǃ-CD was patented (Prošek et al., 2005). The physicochemical characteristics of the resulting 
complexes, such as solubility in relation to temperature and pH, and the influence of 
temperature and ultra-violet (UV) light on its stability were also examined (Fir Milivojević et 
al., 2009 a, 2009 b). 
The prepared complex of CoQ10 with ǃ-CD was characterized and quantified using 
chromatographic and spectroscopic techniques; thin layer chromatography (TLC), high 
performance liquid chomatography (HPLC), high performance liquid chromatography 
coupled with mass spectrometry (HPLC/MS), infra red spectrometry (IR), nuclear magnetic 
resonance (NMR). Among these sophisticated techniques, the relatively simple and 
inexpensive TLC gave us some very important and informative results. Identification and 
quantification of CoQ10/ǃ-CD were done with three different TLC procedures (Prošek et al., 
2002), one and two dimensional TLC (Prošek et al., 2004). 
 
Fig. 2. Expected 3D structure of the inclusion complex of -CD and CoQ10 with folded 
isoprene chain  
To prove the enhanced bioavailability of the CoQ10-ǃCD complex, we performed two 
bioequivalence studies. In the first study, the relative bioavailability was investigated for 
two forms: our water-soluble CoQ10 formulation and a commercially available oil-based 
CoQ10 in the form of soft-gel capsules. The bioavailability was determined by measuring the 
plasma CoQ10 levels periodically after administration to a group of beagle dogs. The mean 
value for the baseline plasma concentrations, maximum plasma concentrations (Cmax), time 
of maximum plasma concentration (Tmax), area under the plasma concentration curve AUC(0-
48h), and the elimination half life (t1/2), were determined for both formulations. The results of 
the experiment show the advantage of water-soluble CoQ10 over commercially available 
soft-gel capsules (Fig. 3). This is shown by the nearly three times higher AUC(0-48h), nearly 
two times higher Cmax, and the shortened Tmax from 6 to 4h, where AUC(0-48h) represents the 
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area under the plasma concentration curve, Cmax the maximum plasma concentration, and 
Tmax the elimination half life (Prošek et al., 2008). 
 
Fig. 3. Comparison of CoQ10 absorption in oil capsules and in complexed CoQ10-ǃCD in 
plasma (Prošek et al., 2008) 
A second bioequivalence study was also performed for two formulations, a novel CoQ10 
paste with increased water-solubility and to soft-gel capsules with CoQ10 in soybean oil, but 
this time on human subjects. This single-dose bioequivalence study once again revealed, 
that the oral absorption and bioavailability of CoQ10 can be significantly affected by 
increasing the water solubility with the formation of CoQ10-ǃCD complex, because it 
demonstrates superior bioavailability over the soft-gel capsules (Žmitek et al., 2008). 
3.1 Food with added complex CoQ10-βCD 
The experiments showed that complex CoQ10-ǃCD can be easily and uniformly mixed with 
many food products. We found that the most appropriate foods for this purpose are dairy 
and meat products. These kinds of products can be easily used to increase the daily intake of 
CoQ10, especially for persons having problems with digesting fats and vegetable oils, which 
are normally used as a matrix in non water soluble preparation of CoQ10. Additionally, 
when inclusion complex CoQ10-ǃCD is placed into an environment with a pH below 3, it is 
disintegrated and CoQ10 is released from the ǃ-CD carrier in its natural form. This is the 
reason why a water-soluble substance in the form of a paste with 7-10% of CoQ10 is used as 
a very efficient dietary supplement. It is also suitable for animals and humans who dislike or 
cannot swallow relatively big capsules. 
3.1.1 Dairy products fortified with CoQ10 
To establish which kind of food products are most suitable carriers for our new additive we 
investigated different kinds of dairy products. Nearly 100 different products from retail 
stores were selected and analyzed, as we needed to know the approximate amount of CoQ10 
in different milk products. CoQ10 was extracted with a combination of ethanol – n-hexane 
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extraction and analyzed using HPLC-MS. In Table 1 shows the concentration of CoQ10 in 
milk produced in different Slovenian regions, with different amounts of fat and production 
procedures. The results were measured in the oxidized state as ubiquinone and represent 
the total amount of CoQ10 in the samples. Unfortunately, few studies with reliable results 
have been published with which we could compare our results. The analyzed dairy 
products were divided into 6 groups: milk, yogurts, sour milk products, curds, creams and 
soybean “milk” products. From the obtained measurements it is evident that milk with 
higher amounts of fat has a higher amount of CoQ10 and that sterilized milk prepared from 
concentrates has a lower amount of CoQ10, regardless of the amount of fat in the milk. 
 
Food products  
Fat (%) 
declared 
CoQ10 
(mg/kg) 
Milk 
Fresh cow milk from local farm 3.6 1.90 
Cow milk from the alpine region 3.5 1.57 
Cow milk from the alpine region 1.6 0.66 
Ultra-heat-treated homogenized milk 3.5 1.70 
Ultra-heat-treated homogenized milk 1.6 1.16 
Ultra-heat-treated homogenized milk 0.5 0.46 
Yogurt product 
Yogurt from goat and sheep milk 6.0 0.32 
Yogurt 3.2 1.13 
Yogurt 1.3 0.70 
Yogurt with fruits 3.2 0.72 
Yogurt 2.8 0.78 
Liquid yogurt 1.6 0.76 
Yogurt bioactive 1.5 1.36 
Yogurt bioactive with inulin 1.5 0.86 
Light yogurt with Ca 0.1 0.24 
Yogurt without fat 0.0 0.06 
Sour milk 
products and 
probiotics 
Sour milk 0.1 0.0 
Sour milk 3.2 0.51 
Sour milk 1.6 0.50 
Liquid sour milk 3.6 0.55 
Acidofil drink 3.2 0.91 
Probiotic drink 2.0 0.60 
Kefir 3.5 0.94 
Kefir 1.6 0.68 
Curd and cream 
products 
Cream 35.0 0.92 
Sour cream 21.5 0.90 
Cream for coffee 10.0 0.11 
Curd 34.0 0.68 
Curd pressed 13.4 0.68 
Soy milk and 
soybean product 
Soy drink - 0.03 
Soy yogurt - 0.04 
Soy yogurt with fruit - 0.03 
Table 1. Concentrations of CoQ10 in some milk and milk products, as well as soy milk 
products 
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From acquired results is evident that milk with higher concentration of fat has also higher 
amount of CoQ10 and that sterilized milk prepared from concentrates has a lower amount of 
CoQ10, regardless of the fat concentration. 
The second group shows the concentrations of CoQ10 in different kinds of yogurts are. The 
concentrations of CoQ10 vary from 1 mg/kg in yogurt from natural cow's milk with 3.2% of 
fat to practical zero in special light versions with no declared fat (0%). The sample 
preparation and extractions were not very effective, due to different types of additives in 
some yogurts, especially of plant origin, such as inulin and other sugar polymers. Our 
results show that yogurts produced from natural cow s milk with standardized amounts of 
fat (3.2%) are the right origin for dietary CoQ10. In the sour milk group, the kefir and 
acidophilous drinks' amount of CoQ10 vary from sample to sample, but it is evident that the 
amount of fat correlates with the amounts of CoQ10. The next group shows CoQ10 
concentrations in creams and curds. The measured concentrations are not very high, 
especially if compared with the concentrations of fat in the samples. These types of milk 
products are not very suitable sources of natural CoQ10, as the consumer would have to eat 
too much fats. On the other hand, this type of food, mostly used as a desert, is very good for 
enrichment with herbs and CoQ10. Several soybean products were also analyzed, but we 
found only small amounts of CoQ10 in purchased soy bean drinks and yogurts. 
The measured values together with consumers' nutritional habits show that the milk-based 
dairy products are very convenient candidates for supplementation. Milk products with a 
suitable combination of fat and water are an ideal basise for functional food products 
containing increased amounts of CoQ10. Ubiquinone is a fat soluble substance and a certain 
amount of fat in the carrier food is advantageous. 
3.1.2 Pates fortified with CoQ10 
The second set of food products which can easily be enriched with water soluble CoQ10 are 
different meats (fish, poultry, beef and pork) and liver pates. A certain group of such 
products were purchased from local stores and analyzed. In addition to the concentrations 
of CoQ10, the total amount of fat, fatty acid profiles, and cholesterol were also determined. 
The analyzed samples may be sorted in five groups. Quantitative results are shown in Table 
2. In the first group, typical pork pates are shown; these usually contains: 10-25% pork liver, 
5-30% pork meat, up to 10% pork fat, as well as ham, bacon, intestines, proteins, and 
carbohydrates. Results show a very high amount of CoQ10. The mean value of 9 different 
samples is 12.3 mg/kg, and the maximum value 27.4 mg/kg of CoQ10. There is a high level 
of extracted fat, with a mean value of nearly 24%. In the extracted fat, 40.3% is saturated 
fatty acids and only 17.7% is unsaturated, but nearly 40% is C18:1, which makes these 
products quite resistant to fat oxidation. On the downside, these types of pates do have high 
amount of cholesterol, with an average value of 0.46 g/kg. 
The second group contains pates prepared from poultry meat and liver, with additives in 
the form of milk and soy proteins, vegetable fats, and hydrolyzed carbohydrates. This group 
showed the highest amount of CoQ10 from among the entire group of analyzed samples. The 
mean value of CoQ10 in the 9 different pates is 17.9 mg/kg. The level of total fat is not high 
but is very variable: the mean value is 19.9% and the maximal value is 30.8%. The variability 
is probably the result of different concentrations of vegetable fat added to the final products. 
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The amount of saturated fatty acids in fat is only 26.4%. The combination of C18:1 and other 
unsaturated fatty acids means there are up to 72.4% unsaturated fatty acids in these poultry 
products. But once again, as in the first group, the main drawback is the very high level of 
cholesterol, with an average value of 0.73 g/kg. This high value is probably the result of the 
high amount of fatty poultry skin in the product. 
 
Pate Pork pate 
Poultry 
pate 
Pork pate with 
vegetables fats 
Beef 
pate 
Fish 
pate 
Components 
Pork 
liver, fat, 
meat 
Poultry 
meat, liver 
Pork meat, 
vegetable fats & 
additives 
Beef 
meat 
Fish 
meat 
Saturated fatty acids 
(%) 
40.3 26.4 39.6 33.1 22.5 
Unsaturated fatty 
acids (%) 
17.7 39.7 16.0 27.6 53.0 
C18:1 (%) 39.7 32.7 42.2 36.9 24.2 
Unsaturated fatty 
acids (sum total) (%) 
57.5 72.4 58.2 64.5 77.2 
Fat g/100 g 23.9 19.9 25.5 21.2 17.0 
CoQ10 g/100 g 1.23 1.79 0.64 0.98 0.63 
Cholesterol g/100 g 0.046 0.073 0.031 0.072 0.050 
Table 2. Quantitative results of fat, fatty acids, CoQ10, and cholesterol in some meat and liver 
pates 
In the third group, pates produced from pork meat and added vegetable fat and 
carbohydrates are presented. In this group the total amount of fat is high and its 
concentration is stable. The main reason is the controlled addition of vegetable fat, which 
also influences the amount of C18:1 and not the high amount of cholesterol, where the 
average value is only 0.3 g/kg. These positive effects are reduced by the relatively low 
amount of CoQ10, averaging only 6.4 mg/kg.  
The fourth group consists of samples prepared from beef meat. These pates have small 
amount of fats, only 21.2%. The level of unsaturated fatty acids is relatively high, the level of 
CoQ10 is acceptable, with an average value of 9.8 mg/kg, but the concentration of cholesterol 
is very high, with an average value of 0.7 g/kg.  
In the last group are pates prepared from fish meat. Although only a small number of 
products were analyzed we can conclude from the obtained results that this group has a low 
amount of CoQ10: the mean value of 4 different pates is 6.3 mg/kg and the maximum value 
is 8.4 mg/kg. The level of total fat is very low, only 17.0%. The amount of saturated fatty 
acids is small (22.5%) and the amount of unsaturated fatty acids is extremely high (53.0%), if 
we include C18:1 it can reach up to 77.2%. The level of cholesterol is low, with an average 
value of 0.50 g/kg. 
Results show that meat and liver pates can be a very good dietary source of CoQ10. The 
concentration is higher than in any other food products, such as in raw milk where the 
concentration of CoQ10 is less than 3 mg/L. The only problem is the high amount of 
cholesterol, which is correlated with amount of CoQ10. In a product with a high amount of 
www.intechopen.com
Poultry Products with Increased Content  
of CoQ10 Prepared from Chickens Fed with Supplemental CoQ10 173 
ubiquinone there is also a high amount of cholesterol present. The relation between CoQ10 
and cholesterol in analyzed samples is shown in Fig. 4. 
A strong correlation between CoQ10 and cholesterol was found; however, there was no 
correlation between total fat and CoQ10 and total fat and cholesterol. This is logical due to 
the different product formulation of meat pates even in cases where they have similar labels. 
The obtained results show that CoQ10 in meat pates is a reasonable supplement. It can 
change the ratio of CoQ10 to cholesterol present in the meat products and makes them more 
suitable for the consumer.  
 
Fig. 4. Relation between concentrations of cholesterol and concentrations of CoQ10 in 
different pates, expressed as the ratio between measured value and the max value on each 
coordinate (cmax(CoQ10) = 2.56 mg/100 g, cmax(cholesterol) = 201 mg/100 g). Group A 
consists of pork liver, fat and meat; B of poultry meat and liver; C of pork meat, vegetable 
fats and additives; D of beef meat; E of fish meat 
4. Poultry products with increased content of CoQ10 
The distribution of exogenous CoQ10 in different tissues has been described mostly in rats 
and mice (Kwong et al., 2002; Kamzalov et al., 2003). In both rats and mice, the predominant 
endogenous form of CoQ is CoQ9, due to their relatively short life span. In humans and 
animals with longer life spans, including chicken, the major homologue is CoQ10. There is a 
lack of studies on feeding long-lived animals with dietary CoQ10 and its distribution in 
tissue, which may explain the accumulation of CoQ10 in animals whose predominant form 
of CoQ10. Until now, there was also not a lot of information available to describe the effect of 
long term controlled supplementation with CoQ10. 
4.1 Influence of added CoQ10 in chicken feed on breeding and its accumulation in 
chicken tissue 
In this study, we present the influence of CoQ10 used as a food additive on the health and 
physical condition of chickens during the feeding period. The amounts of CoQ10 and 
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cholesterol in chickens' blood before slaughtering and in different tissues after slaughtering 
are determined. 
4.1.1 Animals and experimental design 
Two hundred 1-day-old ROSS 308 male chicken broilers were provided from a local 
hatchery (Perutnina Ptuj d.d., Slovenia). The study was carried out under optimal health 
and growing conditions, according to the prepared protocol. During the 40-day production 
period all animals were treated under identical controlled environmental and growing 
conditions with deep litter technology, except for the feed. One hundred chickens were 
treated as the control group (G0) and the other hundred (the group in the study) were 
distributed into four subgroups (G1-G4). The control group of animals was fed plain feed 
for the whole period, while the study group received feed fortified with water-soluble CoQ10 
paste with 7.5% of CoQ10 in the form of inclusion complex with ǃ-cyclodextrin. The active 
substance was synthesized in our laboratory (Laboratory for Food Chemistry, National 
Institute of Chemistry, Ljubljana, Slovenia) and mixed with the fodder in two steps in order 
to give a final concentration of 0.0042% CoQ10. The concentration of CoQ10 in feed was 
calculated so that each animal received an average of approximately 5 mg of CoQ10 per day. 
The subgroup G4 was fed with fortified feed for the whole period of 40 days. The subgroups 
G1, G2, and G3 were fed with fortified feed for the last 10, 20 and 30 days of the 40-day 
production period, respectively (Table 3). 
 
Group of chicken G0 G1 G2 G3 G4 
Start of feeding (on day of age) / 30th 20th 10th 0th 
Time of feeding with CoQ10 (number of days) / 10 20 30 40 
Content of CoQ10 in feed (mg/day) / 5 5 5 5 
Number of chicken 109 25 25 25 25 
Table 3. Experimental design of feeding chicken with added CoQ10 
At the end of day 40, before slaughtering, blood samples from 20 randomly chosen birds 
were collected in commercially available heparinized tubes, centrifuged at 3000 g for 15 min 
and immediately frozen at -80 °C. After slaughtering, 6 birds were randomly chosen from 
each of the subgroups and several chicken parts (heart, liver, breast, leg, wing and body fat) 
were separately sampled, labelled, packed, and frozen at -20°C. After about 24 hours the 
collected frozen samples were transported to the laboratory facility for long-term storage at -
80°C and kept so until needed for analysis.  
4.1.2 Growth of chicken 
During the 40 day growth period, chickens were monitored by measuring their body weight 
and by feed intake weighing. Significant changes were noticed in the physical condition of 
chickens over the growth period of 40 days. In Fig. 5, the increase in the chicken weight is 
shown. The net increase in chickens weight in each group is compared to the average value 
of the control group at the corresponding measurement time. In this way the influences of 
higher starting weight of the control groups and non-uniform distribution of groups 
formation (10, 20, 30, 40 days) and weighting times (10, 21, 29, 36, and 40 days), are 
eliminated. Our study showed that a major increase in chicken body mass was seen in group 
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G4, followed by group G2. From the obtained results, we can conclude that the most 
economical results would be obtained with non-stop twenty days foddering. 
 
Fig. 5. Influence of exogenous CoQ10 on chicken body mass (g) in groups (G0, G1, G2, G3 in 
G4) on day 10 (1st weighing), on day 21 (2nd weighing), on day 29 (3rd weighing), on day 36 
(4th weighing) and on day 40 (5th weighing) of chicken age 
We also observed that the addition of CoQ10 had a strong influence health during breeding. 
Due to their fast growth, chickens are vulnerable to a number of diseases. Ascites is the most 
common metabolic disease in chicken and occur worldwide, especially at high altitudes. The 
disease has a complex aetiology and is predisposed to by reduced ventilation, and 
respiratory disease (Currie, 1999). The literature data has demonstrated the positive effect of 
exogenous CoQ10 in reducing ascites mortality in broilers (Geng et al., 2004). 
4.1.3 Accumulation of CoQ10 in plasma and various tissues 
Four different groups of broiler chicken were administered CoQ10 for the last 10, 20, 30, and 
40 days prior to slaughter, after which the amounts of CoQ10 and cholesterol were measured 
in plasma, liver, heart, breast, wings, and legs. The results for CoQ10 (Fig. 6) and cholesterol 
concentrations (Fig. 7) in different samples from chickens were obtained by HPLC-MS and 
TLC methods, respectively.  
After ingestion of feed enriched with CoQ10, molecules of CoQ10 were transferred with other 
lipids via chylomicrons to liver cells. The results showed that the concentration of CoQ10 in 
the liver after feeding with feed fortified with CoQ10 in the various test groups is not 
statistically significantly changed in comparison to the control group. The liver, probably 
through unknown mechanisms, regulated the concentration of endogenously synthesized 
CoQ10. In liver tissue cholesterol concentration increased. 
In the liver, CoQ10 was incorporated into lipoproteins, mostly into VLDL/LDL particles 
and released into the circulation. The major function of CoQ10 in the blood is as an 
antioxidant. CoQ10 protects LDL from lipid peroxidation by scavenging peroxyl radicals 
(Alleva et al., 1995, 1997). The antioxidant protection is important for broiler chickens 
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because of their rapid growth and consequent higher feed intake per time-unit and higher 
metabolic rate.  
The concentration of CoQ10 in plasma increased in all test groups by approximately 1.6-fold 
over that in the control group. CoQ10 levels in blood also exhibited a noticeable maximum 
increase of about 80% in the case of group G3. However, the concentrations declined with 
prolonged, 40-day supplementation (group G4) to 140% of the levels found in the control 
group (G0). In the case of blood levels, a variety of values within each group were found, 
leading to large differences in the relative standard deviations of the measurements. The 
highest relative standard deviations values were found in the blood samples of groups G0 
and G4, where they reached up to 20% and 28%, respectively, while in other groups the 
values were in the range of 13-16%. The variability in blood levels, on the other hand, 
reflects the differences among individual animals in response to CoQ10 supplementation. 
Moreover, blood levels are more time-dependent over a short timescale compared to tissues, 
as blood is the transport medium of an organism. It was necessary to average the results for 
blood CoQ10 levels to obtain a meaningful value as the levels varied so much among 
individual animals. 
The concentration of cholesterol decreased in blood in all groups. The biggest changes were 
noted in G4 group, after 40 days of feedings chickens with CoQ10. This kind of results are 
expecting according to the data from literature (Honda et al., 2010).  
 
Fig. 6. Relative changes in CoQ10 concentration during the 40 day feeding period 
CoQ10 is transferred from the blood into various tissue and organs. In this study the 
concentration of CoQ10 was examined in heart and muscle tissues (legs, breast and wings). 
CoQ10 is present in all tissue and cells but, on a weight basis, in variable amounts. The 
highest content of CoQ10 was founded in the most active organs like the heart, kidney, and 
liver (Ernsten & Dallner, 1995).  
Statistically, the content of CoQ10 increased in the hearts of chickens with longer periods of 
feeding with supplemental CoQ10, but only in the range of 7.3% - 11.3%, which is low 
compared with muscle tissue. Since the supplemented chickens are young organisms, we 
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therefore assumed that the heart does not require additional CoQ10. In heart tissue, 
concentration of cholesterol was nearly 10 % lower than in the control group. 
In the analysis of the muscle tissue, we found that most of the CoQ10 was found in legs (cca 
22 mg/kg), with significantly less in breast (cca 9 mg/kg) and wings (cca 7 mg/kg). The 
results of our study showed that the added CoQ10 increased CoQ10 concentration in all 
muscle tissue (legs, wings and breast). After 40 days of feeding with feed fortified with 
CoQ10 the content of CoQ10 increased most in breast (45%), followed by wings (25%) and 
legs (16%). At the same time, concentration of cholesterol in breast, wings and legs are not 
significantly changed. 
 
Fig. 7. Relative changes in cholesterol concentration during the 40 day feeding period  
The influence of added CoQ10 on cholesterol concentration was not statistically significant. 
In the analyzed chicken meat we calculated the QCI (CoQ10/cholesterol index) (1), which 
represents a measure of the improvement in the quality of the meat (Fig.8). 
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 (1) 
The calculated QCI values obtained from the analyses of individual samples from 
individual animals proved to be a better means of studying CoQ10 profiles, than the use of 
absolute CoQ10 and cholesterol concentrations. The QCI was used, since according to our 
previous experiments, it is a very reliable indicator of the oxidative status and possible 
oxidative stresses activated by the food ingredients. We hope that this index will soon 
receive adequate attention as an informative factor in the evaluation of possible harmful 
effects of oxidants in foods. The QCI increased in all parts of the chicken, except in the wings 
where after 10 days of supplemental CoQ10 feeding, it fell by 9% and after 20 days of 
supplemental CoQ10 feeding the value by comparison with the control group hardly 
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changed. The biggest improvement was achieved in the breast, where, after 20 days of 
feeding, the QCI relative change index increased by almost 50%.  
 
Fig. 8. Relative changes in the QCI (QCI = CoQ10 (mg/kg)/cholesterol (mg/kg)*1000 index) 
in different chicken muscle tissue in test groups with different periods of feeding with 
CoQ10 
The optimal time of feeding with CoQ10 in comparison with the content of supplemental 
CoQ10 (mg) during chicken raising was also of interest to this study (Fig. 9). Chicken under 
prolonged feeding with exogenous CoQ10 received different amount of CoQ10. Chicken in 
group G0, G1, G2, G3 and G4 received 0, 50, 100, 150 and 200 mg of CoQ10, respectively. The 
results indicated that the highest increase in the concentration of CoQ10 was after 20 days of 
feeding, when chicken received 100 mg of CoQ10.  
 
Fig. 9. Relative changes in CoQ10 (%) in chicken meat (legs, wings and breast) in comparison 
with the content of supplemental CoQ10 (mg) during chicken raising 
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4.2 Transfer of dietary CoQ10 into different parts of chicken breast cells  
The biggest difference between the concentration of CoQ10 in the test group G0 and control 
group G4 was found in the breast tissue (Fig.10). This is the reason why this material was 
selected for further processing. The selected breast tissue was fractionated into four fractions 
(Fig. 11) essentially following the procedure from the literature (Casado et al., 1992). 
Fraction P1 contain mainly nucleus and cell debris, P2 included mitochondria, P3 consist of 
smaller cell organelles and the remaining S3 fraction was composed of cytosol and small 
section of disintegrated cell and organelle membranes. 
 
Fig. 10. Relative changes in the concentration of CoQ10 in several chicken tissue (legs, breast 
and wings) after 40 days of chicken feeding (G4 group) normalized to the control group (G0 
group) 
 
Fig. 11. Fractionation scheme of chicken homogenate (P1 is the nuclear fraction, P2 is the 
mitochondrial fraction, P3 is the microsomal fraction and S3 is the remaining supernatant) 
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The concentration of cholesterol differed between the subcellular fractions within each 
group (P1-P3, S3), but showed practically no difference between groups (G0, G4). At the 
same time, there were significant differences in the CoQ10 concentrations with in groups and 
between fractions in the control and test groups (Table 2). With regard to these results, we 
decided to normalize the concentrations of CoQ10 to cholesterol concentrations and not to 
the protein concentrations that are normally used. The QCI was calculated for all fractions in 
both groups. The results in Fig. 12 show that the CoQ10 concentration in the P1 fraction of 
the G4 group increased by approximately 3 times compared to the control group, 
meanwhile the increase in the P3 and P4 fraction was merely approximately 30%, but in P2 
the amount of CoQ10 remained unchanged.  
 
Fig. 12. Values of the QCI analysed by HPLC in different fractions and in the control group 
G0 and in the G4 test group that received CoQ10 (5mg/day) for 40 days 
The obtained results showed that most of the administered CoQ10 was located inside the cell 
membranes. This is seen from the increase in CoQ10 concentrations in fraction F1, which 
consisted mostly of the nucleus, partially disintegrated cells, and large cell debris, and 
cytosol fraction F4 in which small parts of completely disintegrated cell membranes were 
found. A small increase was also noticed in fraction F3, in which smaller organelles were 
accumulated. It is very interesting that there is no change in the concentrations of CoQ10 and 
cholesterol in the crude mitochondrion fraction (F2). The observed variations in CoQ10 
distribution indicate that supplementary ubiquinone was mainly built into the cell 
membranes and not into the mitochondria. Theoretically, the maximum increase was 
expected for the mitochondrial fraction, due to the essential role of CoQ10 in energy 
conversion. However, the observed accumulation pattern of CoQ10 in the nuclear and 
cytosolic fractions is likely due to other less known or even unknown metabolic functions. In 
addition, our results are in significant accordance with the concept of the antioxidant action 
of exogenous supplied CoQ10, which is now promoted by Littarru (1994).  
In our study, young and healthy animals, who likely have sufficient amounts of endogenous 
CoQ10, were used and this could be the main reason why the exogenous addition was built 
into the cell membranes and not into the mitochondrion inner membranes.  
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4.3 Poultry products with an increased content of CoQ10 
The majority of consumers refuse to eat meat with higher levels of fat, due largely to the 
possible association between high levels of cholesterol and heart disease. Poultry meat and 
poultry products are widely consumed due to their lower content of cholesterol than other 
meat, faster digestibility, and price accessibility. Meat is a rich source of essential amino 
acids, minerals, some vitamins, and long chain polyunsaturated fatty acids. Thus, a 
moderate intake of meat is important part of balanced diet. 
Supplementary dietary CoQ10 present in food or taken as a dietary supplement is widely 
consumed because of its beneficial effect on human health. Supplementation with CoQ10 has 
been shown to improve the resistance of LDL particles to oxidation and to prevent 
atherogenicity (Hanaki et al., 1993; Witting et al., 2000). 
The aim of our work was to prepare food with an increased content of CoQ10 from chicken 
fed with supplemental CoQ10. This procedure of preparing food with supplemental CoQ10 
by direct feeding provided also health benefits to the chicken.  
4.3.1 Animals and experimental design 
Two groups of 1-day-old ROSS 308 male chickens were obtained from the regular hatching 
process in a poultry hatchery. The control group of animals (36600 chickens) was fed plain 
feed for the whole period, while the study group (37000 chickens) received the last 20 day 
feed fortified with water-soluble CoQ10-ǃCD. The shortened feeding period was selected 
because the laboratory experiment showed that a major increase in the concentration of 
CoQ10 in meat tissue was provoked after the twenty-day administration period. The 
concentration of CoQ10 in feed was calculated so that each animal received an average of 
approximately 5 mg of CoQ10 per day. A set of poultry food products (breaded chicken 
wings, breaded chicken drumsticks, breaded chicken fillet, chicken nuggets, extra chicken 
sausages, and chicken liver pate) was prepared from the meat and organs (liver, heart) of 
the test animals according to usual industrial procedures. Concentrations of CoQ10 and 
cholesterol were evaluated using two reliable analytical procedures, quantitative HPLC-MS 
and semi-quantitative TLC. 
4.3.2 QCI in poultry products 
The content of CoQ10 increased as expected in all chicken products, while the 
concentration of cholesterol were only slightly reduced. The content of CoQ10 
concentration in different chicken meat and their products are shown in Fig. 13. The 
results show that the poultry pates contain the highest value of CoQ10. The concentration 
of CoQ10 increased in all poultry products according to the increased value of CoQ10 in the 
fortified chicken meat. 
From the obtained results we calculated the QCI to determine the improvement in meat 
quality. The relative changes in the QCI concentration normalized to the control group are 
presented in Fig. 14. The results show the improvement for the fortified poultry products. 
The highest increase in the QCI was obtained in fortified chicken nuggets (220%) and in 
breaded chicken wings (206%).  
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Fig. 13. CoQ10 concentration (mg/kg) in different meat (breast, wings and legs) and in 
different poultry products (breaded chicken wings, breaded chicken drumsticks, breaded 
chicken fillet, chicken nuggets, extra chicken sausages, and chicken liver pate) 
 
Fig. 14. Relative changes in the QCI (%) in different poultry products normalized to control 
groups 
The CoQ10 content in people's diets was determined to be 3-6 mg per day, primarily derived 
from meat. The fortified chicken liver pate contains an average of 52.7 mg CoQ10/kg sample, 
meaning that if the consumer ingests 100 g of the product, he/she gets approximately 5.3 mg 
of CoQ10. Breaded chicken wings, breaded chicken drumsticks and breaded chicken fillets 
contain large amounts of CoQ10, but these are products that require heating prior to ingestion. 
Weber et al. (1997) studied the loss of CoQ10 during food preparation. The results showed that 
frying reduces CoQ10 levels by 14-32%, while boiling does not reduce CoQ10 levels.  
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Food that contains CoQ10, is a more complex matrix than capsules. The absorption of the 
various components of food from the gastrointestinal tract is one of the major determinants 
of bioavailability. Literature data indicate that intestinal absorption of food accelerates 
CoQ10 absorption (Ochiai et al., 2007). It is known that foods containing fat promote the 
excretion of bile acids, which form micelles water-insoluble components and thus increase 
the possibility of absorbtion through the gastrointestinal tract. Fear that the enriched 
products will exceed the current recommended daily dose, which should amount to 30 
mg/day, is not grounded. In fact, these fortified products would increase the intake of 
CoQ10, which numerous studies indicate to be positive.  
5. Conclusions 
Coenzyme Q10 is a key component in the inner mitochondrial membrane, where it plays 
important role in oxidative phosphorylation. It is also present in other subcellular fractions 
and in plasma lipoproteins, where it has antioxidant properties. CoQ10 has also been 
recognized to have an effect on gene expression. These three functions are important for its 
use in clinical practice and as a food supplement. A large number of clinical studies indicate 
that dietary CoQ10 administration has beneficial effects, particularly in cardiomyopathies, as 
well as degenerative muscle and neurodegenerative diseases. 
The bioavailability of CoQ10 is relatively low due to its lipophilic nature and relatively high 
molecular mass. Increasing the availability of CoQ10 in aqueous medium could consequently 
also increase its bioavailability, which can be achieved by complexing CoQ10 with ǃ-CD.  
The aim of our work was to study the effect of added CoQ10 in water soluble form in chicken 
feed on broiler chicken and to prepare functional chicken products with biologically 
incorporated CoQ10. The weighing of chicken showed that the greatest growth was achieved 
in chicken groups where the chickens were fed with added CoQ10 for 40 days.  
The results of our study showed that added CoQ10 increased CoQ10 concentration in plasma, 
heart, and in chicken meat (breast, legs, wings). The added CoQ10 decreased cholesterol 
concentration in the heart and in plasma. The highest increase in CoQ10 concentration was 
observed in chicken breast cells after 40 days of feeding with CoQ10 added in feed. 
Fractionation of chicken breast cells showed that the added CoQ10 was mainly incorporated 
into cell membranes and not into mitochondria. This confirmed our hypothesis that CoQ10 
added in chicken tissues acts mostly as an antioxidant.  
In the industrial experiment, chickens were fed with CoQ10 added in feed for the last 20 days 
before slaughtering and the functional products were prepared from meat fortified with 
CoQ10. As excepted, the content of CoQ10 increased in all chicken products especially in 
breaded chicken fillet, while nearly in all meat tissues concentration of cholesterol was slightly 
reduced which increased the QCI. We presume that, QCI can be used as useful indicator in 
meat nutritional quality which also indicates better growing conditions for chickens regarding 
to oxidative stress. Fortified chicken products can have a positive effect on consumer's health. 
Accumulated CoQ10 together with simultaneously absorbed fats can protect non-saturated fats 
from uncontrolled oxidation and consequently reduce the risk of different diseases. 
In the next research period, we will deal with the importance of antioxidant network in 
preventing of oxidative stress. We also expect that the obtained results will help us to get 
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enough information to design new functional food and feed additives and to provide better 
breeding production of chickens. 
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